Loading...

argenx SE

ARGXNASDAQ
Healthcare
Biotechnology
$575.42
$4.19(0.73%)

argenx SE (ARGX) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 79.3/100

Key Financials

Market Cap35.2B
P/E Ratio32.85
EPS (TTM)$16.42
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Week$577.99
1 Month$670.72
3 Months$759.96
1 Year Target$687.71

ARGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $687.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.85 and a market capitalization of 35.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;